|
1) Barceló A, Miralles C, Barbé F, et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J. 2000; 16: 644-7
|
|
|
|
2) Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004; 27: 123-8
|
|
|
|
|
|
3) Cofta S, Wysocka E, Piorunek T, et al. Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol. 2008; 59: 183-90
|
|
|
|
|
|
4) Schulz R, Mahmoudi S, Hattar K, et al. Enhance release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med. 2000; 162: 566-70
|
|
|
|
|
|
5) Saarelainen S, Lehtimaki T, Jaak-kola O, et al. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med. 1999; 37: 517-20
|
|
|
|
|
|
6) Carpagnano GE, Kharitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002; 122: 1162-7
|
|
|
|
|
|
7) Oztürk L, Mansour B, Yuksel M, et al. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta. 2003; 332: 83-8
|
|
|
|
|
|
8) Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J. 2005; 26: 2435-39
|
|
|
|
|
|
9) Kizawa T, Nakamura Y, Takahashi S, et al. Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea. Eur Respir J. 2009; 34: 1390-8
|
|
|
|
|
|
10) Ross R. Atherosclerosis -an inflammatory disease. N Engl J Med. 1999; 340: 115-26
|
|
|
|
|
|
11) Ivan M, Kondo K, Yang H, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001; 292: 464-8
|
|
|
|
|
|
12) Imagawa S, Yamaguchi Y, Higuchi M, et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood. 2001; 98: 1255-7
|
|
|
|
|
|
13) Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and sever nighttime hypoxia. Am J Respir Crit Care Med. 2002; 165: 67-70
|
|
|
|
|
|
14) Lavie L, Kraiczi H, Hefetz A, et al. Plasma vascular endothelial growth factor in sleep apnea syndrome. Effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med. 2002; 165: 1624-8
|
|
|
|
|
|
15) Takahashi S, Nakamura Y, Nishijima T, et al. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med. 2005; 99: 1125-31
|
|
|
|
|
|
16) Møller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003; 16: 274- 80
|
|
|
|
|
|
17) Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7
|
|
|
|
|
|
18) Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353: 999-1007
|
|
|
|
|
|
19) Fadini GP, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol. 2008; 28: 997-1004
|
|
|
|
|
|
20) Robb AO, Mills NL, Smith IB, et al. Influence of menstrual cycle on circulating endothelial progenitor cells. Hum Reprod. 2009; 24: 619-25
|
|
|
|
|
|
21) Martin K, Stanchina M, Kouttab N, et al. Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea. Lung. 2008: 186: 145-50
|
|
|
|
|
|
22) de la Paña M, Barceló A, Barbe F, et al. Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration. 2008; 76: 28-32
|
|
|
|
|
|
23) Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008; 117: 2270-8
|
|
|
|
|